| Description | VMY-1-101 is a synthesized fluorescent CDK inhibitor. VMY-1-101 demonstrates potent CDK inhibitory activity, enhanced induction of G2/M arrest and modest apoptosis as compared to purvalanol B. |
| molecular weight | 694.25 |
| Molecular formula | C33H40ClN9O4S |
| CAS | 1209002-42-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |